4072 related articles for article (PubMed ID: 10946879)
21. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
[TBL] [Abstract][Full Text] [Related]
22. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism.
Pasquali R; Casimirri F; Cantobelli S; Labate AM; Venturoli S; Paradisi R; Zannarini L
Horm Res; 1993; 39(5-6):179-87. PubMed ID: 8314200
[TBL] [Abstract][Full Text] [Related]
23. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
[TBL] [Abstract][Full Text] [Related]
24. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
25. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.
Crave JC; Fimbel S; Lejeune H; Cugnardey N; Déchaud H; Pugeat M
J Clin Endocrinol Metab; 1995 Jul; 80(7):2057-62. PubMed ID: 7608255
[TBL] [Abstract][Full Text] [Related]
26. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
27. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
[TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
29. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
[TBL] [Abstract][Full Text] [Related]
30. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
[TBL] [Abstract][Full Text] [Related]
31. Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS.
Van Dam EW; Roelfsema F; Veldhuis JD; Helmerhorst FM; Frölich M; Meinders AE; Krans HM; Pijl H
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E865-72. PubMed ID: 11882506
[TBL] [Abstract][Full Text] [Related]
32. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
[TBL] [Abstract][Full Text] [Related]
33. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
34. Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome.
Kowalska I; Kinalski M; Straczkowski M; Wolczyski S; Kinalska I
Eur J Endocrinol; 2001 May; 144(5):509-15. PubMed ID: 11331217
[TBL] [Abstract][Full Text] [Related]
35. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
[TBL] [Abstract][Full Text] [Related]
38. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
39. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA; Lewy V; Danadian K; Saad R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
[TBL] [Abstract][Full Text] [Related]
40. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
Yucel A; Noyan V; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
